Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (99) 99
cancer och onkologi (82) 82
cancer and oncology (81) 81
surgery (69) 69
oncology (67) 67
female (65) 65
male (57) 57
middle aged (51) 51
adult (49) 49
index medicus (49) 49
medicin och hälsovetenskap (47) 47
medical and health sciences (46) 46
aged (44) 44
kirurgi (39) 39
cancer (38) 38
animals (34) 34
klinisk medicin (33) 33
clinical medicine (32) 32
melanoma (21) 21
rats (21) 21
administration & dosage (19) 19
cisplatin (19) 19
drug therapy (19) 19
therapy (19) 19
liver neoplasms (18) 18
survival (18) 18
chemotherapy (17) 17
pathology (17) 17
analysis (16) 16
metabolism (16) 16
pharmacology (16) 16
therapeutic use (16) 16
aged, 80 and over (15) 15
colorectal cancer (15) 15
immunotherapy (15) 15
medicine (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
drug effects (14) 14
histamine (13) 13
interleukin-2 (13) 13
liver neoplasms - secondary (13) 13
prognosis (13) 13
treatment outcome (13) 13
diagnosis (12) 12
europe (12) 12
mortality (12) 12
experimental (11) 11
hematology, oncology and palliative medicine (11) 11
melanoma - drug therapy (11) 11
melanoma - pathology (11) 11
patients (11) 11
blood supply (10) 10
immunology (10) 10
liver (10) 10
nk cells (10) 10
research (10) 10
survival analysis (10) 10
survival rate (10) 10
sweden (10) 10
tumors (10) 10
5-fluorouracil (9) 9
adenocarcinoma - pathology (9) 9
carcinoma (9) 9
clinical trials (9) 9
histamine - administration & dosage (9) 9
interleukin-2 - administration & dosage (9) 9
liver cancer (9) 9
mice (9) 9
neoplasms (9) 9
pharmacokinetics (9) 9
antineoplastic combined chemotherapy protocols (8) 8
cell biology (8) 8
cell line, tumor (8) 8
cells (8) 8
chemistry (8) 8
colorectal neoplasms (8) 8
colorectal neoplasms - pathology (8) 8
fluorouracil (8) 8
fluorouracil - administration & dosage (8) 8
hepatic artery (8) 8
immunohistochemistry (8) 8
infusions (8) 8
interferon-alpha (8) 8
metastasis (8) 8
neoplasm staging (8) 8
neoplasms - therapy (8) 8
physiology (8) 8
reactive oxygen metabolites (8) 8
resistance (8) 8
adenocarcinoma (7) 7
antineoplastic agents (7) 7
audit (7) 7
basic medicine (7) 7
biochemistry (7) 7
biochemistry & molecular biology (7) 7
blood (7) 7
case-control studies (7) 7
combination (7) 7
drug resistance (7) 7
growth (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Delivering affordable cancer care in high-income countries
by Sullivan, Richard, Prof and Peppercorn, Jeffrey, Prof and Sikora, Karol, Prof and Zalcberg, John, Prof and Meropol, Neal J, Prof and Amir, Eitan, MBChB and Khayat, David, MD and Boyle, Peter, Prof and Autier, Philippe, PhD and Tannock, Ian F, Prof and Fojo, Tito, MD and Siderov, Jim, MClinPharm and Williamson, Steve, MRPharmS and Camporesi, Silvia, PhD and McVie, J Gordon, Prof and Purushotham, Arnie D, Prof and Naredi, Peter, Prof and Eggermont, Alexander, Prof and Brennan, Murray F, Prof and Steinberg, Michael L, Prof and De Ridder, Mark, Prof and McCloskey, Susan A, MD and Verellen, Dirk, Prof and Roberts, Terence, MD and Storme, Guy, Prof and Hicks, Rodney J, Prof and Ell, Peter J, Prof and Hirsch, Bradford R, MD and Carbone, David P, Prof and Schulman, Kevin A, Prof and Catchpole, Paul, PhD and Taylor, David, Prof and Geissler, Jan, PhD and Brinker, Nancy G and Meltzer, David, Prof and Kerr, David, Prof and Aapro, Matti, Prof and Medicinska fakulteten and Kirurgi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 10, pp. 933 - 980
Summary The burden of cancer is growing, and the disease is becoming a major economic expenditure for all developed countries. In 2008, the worldwide cost of... 
Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | COST-EFFECTIVENESS ANALYSIS | HEALTH-TECHNOLOGY-ASSESSMENT | ERLOTINIB PLUS GEMCITABINE | STAGE BREAST-CANCER | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RANDOMIZED PHASE-III | CLINICAL-TRIALS | BODY RADIATION-THERAPY | ADVANCED PANCREATIC-CANCER | Health Expenditures - legislation & jurisprudence | Neoplasms - economics | Delivery of Health Care, Integrated - legislation & jurisprudence | Health Care Costs - legislation & jurisprudence | United States | Europe | Humans | Health Services Accessibility - legislation & jurisprudence | Neoplasms - diagnosis | Models, Economic | Health Care Reform - economics | Health Services Misuse - economics | Health Services Research | Socioeconomic Factors | Cost Savings | Health Services Accessibility - economics | Neoplasms - therapy | Healthcare Disparities - economics | Delivery of Health Care, Integrated - economics | Cost-Benefit Analysis | Australia | Health Policy - economics | Insurance, Health - economics | Drugs | Medical colleges | Care and treatment | Oncology, Experimental | Leukemia | Radiation | Research | Cancer | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Circulating Carnosine Dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer
by Arner, Peter and Henjes, Frauke and Schwenk, Jochen M and Darmanis, Spyros and Dahlman, Ingrid and Iresjö, Britt-Marie and Naredi, Peter and Agustsson, Thorhallur and Lundholm, Kent and Nilsson, Peter and Rydén, Mikael and Proteomik och nanobioteknologi and Skolan för bioteknologi (BIO) and KTH
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0123566
Background Cancer cachexia (CC) is linked to poor prognosis. Although the mechanisms promoting this condition are not known, several circulating proteins have... 
PALLIATIVE CARE | DEFINITION | CACHEXIA | METABOLISM | LIPOLYSIS | MULTIDISCIPLINARY SCIENCES | TISSUE | FAT | DIABETIC-NEPHROPATHY | SERUM | CNDP1 | Cachexia - mortality | Adenocarcinoma - pathology | Prognosis | Adenocarcinoma - blood | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Cachexia - blood | Dipeptidases - blood | Biomarkers, Tumor - blood | Stomach Neoplasms - blood | Cachexia - pathology | Survival Analysis | Female | Aged | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Cohort Studies | Proteins | Gastrointestinal cancer | Health aspects | Analysis | Biotechnology | Immunoassay | Disease | Laboratories | Insulin-like growth factor I | Glioblastoma | Science | Antibodies | Gallbladder diseases | Amino acids | Carnosine | Metastasis | Medical diagnosis | Ovarian cancer | Metastases | Dipeptidase | Rodents | Surgery | Oxidation | Malnutrition | Pancreas | Pancreatitis | Weight loss | Cachexia | Apolipoproteins | Patients | Quality of life | Screening | Hospitals | Medical prognosis | Pancreatic cancer | Proteomics | Design factors | Biomarkers | Catabolism | Plasma levels | Diabetes | Prostate cancer | Prostate | Cancer | unclassified drug | Medical and Health Sciences | Medicin och hälsovetenskap | cohort analysis | somatomedin C | Article | catabolism | blood analysis | weight reduction | clinical article | metastasis | outcome assessment | female | human | enzyme blood level | validation process | proteomics | dipeptidase | cachexia | digestive system cancer | cancer prognosis | disease association | enzyme immunoassay | malnutrition | prostate cancer | glioblastoma | carnosine dipeptidase 1 | controlled study | albumin | adult | quality of life | male
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Brittens 'Peter Grimes'
by Naredi-Rainer, E
OSTERREICHISCHE MUSIKZEITSCHRIFT, ISSN 0029-9316, 2003, Volume 58, Issue 5, pp. 51 - 53
MUSIC
Journal Article
Details down arrow
4. Full Text The effect of active warming in prehospital trauma care during road and air ambulance transportation - a clinical randomized trial
by Lundgren, Peter and Henriksson, Otto and Naredi, Peter and Björnstig, Ulf
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, ISSN 1757-7241, 10/2011, Volume 19, Issue 1, pp. 59 - 59
Background: Prevention and treatment of hypothermia by active warming in prehospital trauma care is recommended but scientifical evidence of its effectiveness... 
Passive warming | Thermal comfort | Prehospital trauma care | Emergency medical services (EMS) | Body temperature regulation | Active warming | Hypothermia | emergency medical services (EMS) | RISK-FACTOR | EMERGENCY MEDICINE | hypothermia | active warming | passive warming | prehospital trauma care | thermal comfort | body temperature regulation | Hypothermia - prevention & control | Humans | Middle Aged | Air Ambulances | Wounds and Injuries - complications | Male | Treatment Outcome | Bedding and Linens | Hypothermia - etiology | Body Temperature - physiology | Chi-Square Distribution | Rewarming - methods | Statistics, Nonparametric | Adult | Female | Emergency Medical Services - methods | Ambulances | Physiological aspects | Care and treatment | Heart beat | Research | Wounds and injuries | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Centers of excellence or excellence networks: The surgical challenge and quality issues in rare cancers
by Sandrucci, S and Naredi, Peter and Bonvalot, S and Göteborgs universitet and Institutionen för kliniska vetenskaper, Avdelningen för kirurgi and Gothenburg University and Institute of Clinical Sciences, Department of Surgery and Sahlgrenska Academy and Sahlgrenska akademin
European Journal of Surgical Oncology, ISSN 1532-2157, 2018
© 2018 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. There are several suggestions that... 
Centralization | Health networks | Surgery | Surgical care | Cancer and Oncology | Kirurgi | Cancer och onkologi | Excellence centers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Isolated limb perfusion with melphalan triggers immune activation in melanoma patients
by Johansson, Junko and Kiffin, Roberta and Andersson, Annica and Lindnér, Per and Naredi, Peter L and Bagge, Roger Olofsson and Martner, Anna and Institutionen för biomedicin, avdelningen för infektionssjukdomar and Göteborgs universitet and Gothenburg University and Institutionen för kliniska vetenskaper, Avdelningen för kirurgi and Institute of Clinical Sciences, Department of Surgery and Sahlgrenska Cancer Center and Sahlgrenska Academy and Institute of Biomedicine, Department of Infectious Medicine and Sahlgrenska akademin
Frontiers in Oncology, ISSN 2234-943X, 2018, Volume 8, p. 570
Hyperthermic isolated limb perfusion with melphalan (M-ILP) is a treatment option for melanoma patients with metastases confined to the limbs. This study aimed... 
Monocytes | Cytotoxic T cells | Melanoma | Melphalan | Isolated limb perfusion | monocytes | melphalan | CALRETICULIN | METASTASES | melanoma | ANTIGENS | CHEMOTHERAPY | isolated limb perfusion | ONCOLOGY | IN-TRANSIT MELANOMA | cytotoxic T cells | T-CELLS | LYMPHOCYTES | Drug delivery devices | Usage | Dosage and administration | Research | Drug therapy | lymphocytes | t-cells | antigens | chemotherapy | metastases | calreticulin | in-transit melanoma | Cancer and Oncology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The future of trials in surgical oncology
by Naredi, Peter and La Quaglia, Michael P and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Section for Surgery and Gastrosurgical Research and Education, Department of Surgery and Institutionen för kliniska vetenskaper, sektionen för kirurgi och kirurgisk gastroforskning, Avdelningen för kirurgi and Sahlgrenska Academy
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2015, Volume 12, Issue 7, pp. 425 - 431
Patients with cancer generally have better outcomes when treated as part of a clinical trial compared with patients not enrolled in a clinical trial.... 
BREAST-CANCER | RECTAL-CANCER | HOSPITAL VOLUME | ONCOLOGY | GASTRIC-CANCER | CLINICAL-TRIALS | LAPAROSCOPIC-CHOLECYSTECTOMY | AMERICAN-COLLEGE | NO AXILLARY DISSECTION | RANDOMIZED CONTROLLED-TRIAL | EPIDEMIOLOGY STROBE STATEMENT | Neoplasms - surgery | Surgical Procedures, Operative - education | Humans | Biomedical Research - education | Biomedical Research - methods | Biomedical Research - trends | Clinical Trials as Topic - methods | Surgical Procedures, Operative - trends | Research Design | Education, Medical, Graduate | Research Support as Topic | Clinical trials | Oncology | Excision (Surgery) | Management | Innovations | RANDOMIZED CLINICAL-TRIAL | NO AXILLARY | DISSECTION | PROSTATE-CANCER | Cancer and Oncology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prognostic factors for survival in stage IV rectal cancer: A Swedish nationwide case–control study
by Afshari, Kevin and Chabok, Abbas and Naredi, Peter and Smedh, Kenneth and Nikberg, Maziar
Surgical Oncology, ISSN 0960-7404, 06/2019, Volume 29, pp. 102 - 106
The aim was to identify patient-, tumor- and treatment-related prognostic factors for five-year survival in rectal cancer patients with synchronous stage IV... 
Prognostic factor | Stage IV | Rectal cancer | Metastases | Liver cancer | Prognosis | Gastrointestinal diseases | Analysis | Oncology, Experimental | Liver | Colorectal cancer | Medical records | Metastasis | Research | Cancer | Control methods | Colorectal carcinoma | Medical services | Cardiovascular disease | Cancer therapies | Confidence intervals | Variables | Pain | Surgery | Localization | Signs and symptoms | Comorbidity | Lung diseases | Regression analysis | Radiation therapy | Disease control | Survival | Patients | Studies | Medical prognosis | Rectum | Diabetes | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Future cancer research priorities in the USA: a Lancet Oncology Commission
by Jaffee, Elizabeth M and Dang, Chi Van and Agus, David B and Alexander, Brian M and Anderson, Kenneth C and Ashworth, Alan and Barker, Anna D and Bastani, Roshan and Bhatia, Sangeeta and Bluestone, Jeffrey A and Brawley, Otis and Butte, Atul J and Coit, Daniel G and Davidson, Nancy E and Davis, Mark and DePinho, Ronald A and Diasio, Robert B and Draetta, Giulio and Frazier, A Lindsay and Futreal, Andrew and Gambhir, Sam S and Ganz, Patricia A and Garraway, Levi and Gerson, Stanton and Gupta, Sumit and Heath, James and Hoffman, Ruth I and Hudis, Cliff and Hughes-Halbert, Chanita and Ibrahim, Ramy and Jadvar, Hossein and Kavanagh, Brian and Kittles, Rick and Le, Quynh-Thu and Lippman, Scott M and Mankoff, David and Mardis, Elaine R and Mayer, Deborah K and McMasters, Kelly and Meropol, Neal J and Mitchell, Beverly and Naredi, Peter and Ornish, Dean and Pawlik, Timothy M and Peppercorn, Jeffrey and Pomper, Martin G and Raghavan, Derek and Ritchie, Christine and Schwarz, Sally W and Sullivan, Richard and Wahl, Richard and Wolchok, Jedd D and Wong, Sandra L and Yung, Alfred and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Section for Surgery and Gastrosurgical Research and Education, Department of Surgery and Institutionen för kliniska vetenskaper, sektionen för kirurgi och kirurgisk gastroforskning, Avdelningen för kirurgi and Sahlgrenska Academy
The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. e653 - e706
We are in the midst of a technological revolution that is providing new insights into human biology and cancer. In this era of big data, we are amassing large... 
POSITRON-EMISSION-TOMOGRAPHY | CIRCULATING TUMOR-CELLS | ONCOLOGY | LIFE-STYLE CHANGES | ACUTE LYMPHOBLASTIC-LEUKEMIA | INDUCED PERIPHERAL NEUROPATHY | TARGETED RADIONUCLIDE THERAPY | BODY RADIATION-THERAPY | QUALITY-OF-LIFE | HER2-POSITIVE BREAST-CANCER | SUSCEPTIBILITY GENE-MUTATIONS | Health Planning - trends | Neoplasms - therapy | United States | Humans | Medical Oncology - trends | National Cancer Institute (U.S.) - trends | Precision Medicine - trends | Biomedical Research - methods | Biomedical Research - trends | Neoplasms - diagnosis | Health Priorities | Forecasting | Oncology, Experimental | Research | Cancer | life-style changes | acute lymphoblastic-leukemia | targeted radionuclide therapy | cell lung-cancer | circulating tumor-cells | randomized controlled-trial | Oncology | metastatic breast-cancer | body radiation-therapy | induced peripheral | positron-emission-tomography | neuropathy | Cancer and Oncology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
by Eilard, Malin Sternby and Andersson, Mats and Naredi, Peter and Geronymakis, Charalampos and Lindnér, Per and Cahlin, Christian and Bennet, William and Rizell, Magnus
BMC Cancer, ISSN 1471-2407, 06/2019, Volume 19, Issue 1, pp. 568 - 11
BackgroundPatients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and... 
Liver cancer | Sorafenib | Perfusion CT | Hepatocellular carcinoma | Neoadjuvant | Feasibility | Liver transplantation | TARGETED THERAPY | SURVIVAL | IMPACT | MODIFIED RECIST | ONCOLOGY | RESPONSE EVALUATION CRITERIA | DOUBLE-BLIND | LOCOREGIONAL THERAPY | INCREASED COMPLICATIONS | RECURRENCE | Usage | Relapse | Analysis | Liver | Clinical trials | Transplantation | Hepatoma | Research | Drug therapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights